glp 1 drugs and bipolar disorder Insights into a possible role of glucagon-like peptide-1 receptor agonists in the treatment of depression | Pharmacological Reports Upcoming wave of hormone-based therapies
Description
Failure to rotate application sites adequately represents another common mistake
This dual mechanism distinguishes Mounjaro from traditional GLP-1 receptor agonists, which target only the GLP-1 pathway
A roadmap to achieve pharmacological precision medicine in diabetes
The acute effect of amylin and salmon calcitonin on energy expenditure
Efficacy and safety of canagliflozin in type 2 diabetes mellitus patients with biopsy-proven nonalcoholic steatohepatitis classified as stage 1-3 fibrosis
Kim EK, Choi EJ
